Literature DB >> 17719494

Improved mutasynthetic approaches for the production of modified aminocoumarin antibiotics.

Christine Anderle1, Susanne Hennig, Bernd Kammerer, Shu-Ming Li, Ludger Wessjohann, Bertolt Gust, Lutz Heide.   

Abstract

This study reports improved mutasynthetic approaches for the production of aminocoumarin antibiotics. Previously, the mutasynthetic production of aminocoumarins with differently substituted benzoyl moieties was limited by the substrate specificity of the amide synthetase CloL. We expressed two amide synthetases with different substrate specificity, CouL and SimL, in appropriately engineered producer strains. After feeding of precursor analogs that were not accepted by CloL, but by SimL or CouL, a range of aminocoumarins, unattainable in our previous experiments, was produced and isolated in preparative amounts. Further, we developed a two-stage mutasynthesis procedure for the production of hybrid antibiotics that showed the substitution pattern of novobiocin in the aminocoumarin moiety and that of clorobiocin in the deoxysugar moiety. The substitution pattern of the benzoyl moiety was determined by external addition of an appropriate precursor. Twenty-five aminocoumarin compounds were prepared by these methods, and their structures were elucidated with mass and 1H-NMR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719494     DOI: 10.1016/j.chembiol.2007.07.014

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  9 in total

1.  Characterization of FdmV as an amide synthetase for fredericamycin A biosynthesis in Streptomyces griseus ATCC 43944.

Authors:  Yihua Chen; Evelyn Wendt-Pienkowski; Jianhua Ju; Shuangjun Lin; Scott R Rajski; Ben Shen
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Structural and functional dissection of aminocoumarin antibiotic biosynthesis: a review.

Authors:  David M Lawson; Clare E M Stevenson
Journal:  J Struct Funct Genomics       Date:  2012-05-27

3.  Biological activities of novel gyrase inhibitors of the aminocoumarin class.

Authors:  Christine Anderle; Martin Stieger; Matthew Burrell; Stefan Reinelt; Anthony Maxwell; Malcolm Page; Lutz Heide
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

4.  Structural and functional insight into an unexpectedly selective N-methyltransferase involved in plantazolicin biosynthesis.

Authors:  Jaeheon Lee; Yue Hao; Patricia M Blair; Joel O Melby; Vinayak Agarwal; Brandon J Burkhart; Satish K Nair; Douglas A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

5.  The crystal structure of the novobiocin biosynthetic enzyme NovP: the first representative structure for the TylF O-methyltransferase superfamily.

Authors:  Inmaculada Gómez García; Clare E M Stevenson; Isabel Usón; Caren L Freel Meyers; Christopher T Walsh; David M Lawson
Journal:  J Mol Biol       Date:  2009-10-24       Impact factor: 5.469

Review 6.  Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery.

Authors:  Gina Porras; François Chassagne; James T Lyles; Lewis Marquez; Micah Dettweiler; Akram M Salam; Tharanga Samarakoon; Sarah Shabih; Darya Raschid Farrokhi; Cassandra L Quave
Journal:  Chem Rev       Date:  2020-11-09       Impact factor: 60.622

7.  SimC7 Is a Novel NAD(P)H-Dependent Ketoreductase Essential for the Antibiotic Activity of the DNA Gyrase Inhibitor Simocyclinone.

Authors:  Martin Schäfer; Tung B K Le; Stephen J Hearnshaw; Anthony Maxwell; Gregory L Challis; Barrie Wilkinson; Mark J Buttner
Journal:  J Mol Biol       Date:  2015-04-08       Impact factor: 5.469

Review 8.  Structural insights into simocyclinone as an antibiotic, effector ligand and substrate.

Authors:  Mark J Buttner; Martin Schäfer; David M Lawson; Anthony Maxwell
Journal:  FEMS Microbiol Rev       Date:  2018-01-01       Impact factor: 16.408

9.  Revisiting aminocoumarins for the treatment of melioidosis.

Authors:  S J Willcocks; F Cia; A F Francisco; B W Wren
Journal:  Int J Antimicrob Agents       Date:  2020-04-30       Impact factor: 5.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.